Cannabinoids could eventually be used in the treatment of heart disease. At least that is the expectation of a special team of researchers at the Mount Sinai School of Medicine, who are currently elbow deep in the study of marijuana nanoparticles and how these small pot pods of scientific phenomenon may be the solution to various heart conditions.

Lead researcher and nanoparticle expert Willem Mulder, PhD, says that while his team at the Nanomedicine Laboratory at Mount Sinai has been studying the use of nanoparticles in the treatment of heart disease for the past several years, it wasn’t until recently that the scientists took a specific interest in the healing power of cannabinoids.

In years past, studies published in various scientific journals indicate that cannabinoids have the ability to reduce the advancement of atherosclerosis -- a condition in the arteries associated with many heart conditions. Unfortunately, while the results proved positive in relation to lab rats, the challenges become more complex when testing these compounds on humans.

Dr. Mulder says that producing nano drugs may be a way to bridge the gap between one of the biggest challenges associated with cannabinoid treatment -- the “high” -- and the positive impact these compounds can have on heart health. Dr. Mulder says that by administering cannabinoids through nanoparticles, the psychoactive effects are bypassed because the drug never reaches the brain.

Clinical trials are expected to begin within the next five years, but Dr. Mulder stresses that it could take nearly 15 years before this treatment option is made available.

As a means for creative finance, a documentary filmmaker by the name of Gert van Kempen was recently added to Dr. Mulder’s team. Together, they intend to produce a series of short films tentatively entitled High on Nano, which will be used to educate the public and raise addition funds to further their research.

Mike Adams writes for Playboy's The Smoking Jacket, BroBible and Hustler Magazine. Follow him: @adamssoup; facebook.com/mikeadams73.